Chronic Obstructive Pulmonary Disease Trial Network, Denmark Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02857842
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Coronavirus Infections (Phase 2)

Hypertension (Phase 4)

Hypertension, Pulmonary (Phase 4)

Infections (Phase 2)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Pneumonia (Phase 4)

Pseudomonas Infections (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Respiratory Aspiration (Phase 4)

Respiratory Tract Infections (Phase 4)

Severe Acute Respiratory Syndrome (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9